Definium Therapeutics (DFTX) Treasury Shares (2022 - 2026)

Definium Therapeutics (DFTX) has 4 years of Treasury Shares data on file, last reported at $8.2 million in Q1 2026.

• On a quarterly basis, Treasury Shares rose 37.43% year-over-year to $8.2 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 37.43% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 297.97% from the prior year.
• Treasury Shares for Q1 2026 stood at $8.2 million, up from $5.5 million in the prior quarter.
• Over the last five years, Treasury Shares for DFTX reached as high as $14.0 million in Q1 2022 and fell as low as $792860.0 in Q1 2024.
• Historically, Treasury Shares has averaged $5.1 million across 4 years, with a median of $5.6 million in 2025.
• Across the five-year window, Treasury Shares jumped 650.3% in 2025 and jumped 37.43% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $14.0 million in 2022, then plunged by 90.22% to $1.4 million in 2024, then jumped by 297.97% to $5.5 million in 2025, then surged by 49.81% to $8.2 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $8.2 million in Q1 2026, $5.5 million in Q4 2025, and $5.8 million in Q3 2025.